A team of UCA researchers led by Professor Esther Berrocoso and in joint collaboration with the mental health research groups of the Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) have carried out a ...
Cervel Neurotech has initiated a clinical study for patients suffering from treatment resistant depression at seven leading academic and research centers in the US. The 80-patient trial, designed as a randomized, sham-controlled, double ...
Neuroscience biotech company Cerecor has acquired exclusive, worldwide rights to develop and commercialize MK-0657 from Merck, referred to MSD outside the US and Canada. The small molecule NMDA receptor subunit 2B antagonist MK-0657 will ...
Tags: Cerecor, Global Development Rights, MK-0657
Medical technology company Cyberonics has implanted 100,000th patient using its Vagus Nerve Stimulation (VNS) therapy system. Using implanted medical device, the CE-marked VNS therapy system delivers pulsed electrical signals to the vagus ...
Tags: Cyberonics, Vagus Nerve Stimulator, Health Medicine, Medical technology
Teva Pharmaceutical Industries has launched Olanzapine and Fluoxetine Capsules USP 6mg/25mg, 12mg/25mg, 6mg/50mg, and 12mg/50mg. The Olanzapine and Fluoxetine Capsules are the company's generic equivalent to Symbyax. Lilly USA ...
Tags: Teva Pharmaceutical Industries, Olanzapine and Fluoxetine Capsules